← All Sponsors
SPONSOR

University of Chicago

Total Trials
18
Recruiting
18
Phases
Phase 2, Phase 1, Phase 2, Phase 1, EARLY_Phase 1, Phase 4

University of Chicago is a clinical research sponsor with 18 registered studies on ClinicalTrials.gov, of which 18 are actively recruiting participants. Research covers conditions including HIV Seropositivity, Cancer, Advanced Cancer, Advanced Solid Tumor.

The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Chicago

How many clinical trials has University of Chicago sponsored?
ClinicalMetric currently tracks 18 clinical trials sponsored by University of Chicago, of which 18 are actively recruiting participants. These trials cover conditions including HIV Seropositivity, Cancer, Advanced Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Chicago research focus on?
University of Chicago clinical trials span HIV Seropositivity, Cancer, Advanced Cancer, Advanced Solid Tumor, Mental Health Issue, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Chicago clinical trial?
To participate in a University of Chicago trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Chicago trials with current recruitment status updated daily.

Clinical Trials by University of Chicago

NCT05723653
Recruiting

Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

HIV Seropositivity
NCT05166694
Recruiting

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

Cancer
NCT05726292 Phase 2
Recruiting

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Prostate Cancer
NCT05264051
Recruiting

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

Liver Diseases
NCT04683653 Phase 1, Phase 2
Recruiting

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

Endometrial Cancer
NCT06639503 Phase 1
Recruiting

Genicular Nerve Block After Open Reduction Internal Fixation of Tibial Plateau

Tibial Plateau Fractures
NCT06317701
Recruiting

Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation

Obstructive Sleep Apnea
NCT05700617 EARLY_Phase 1
Recruiting

Cardiac Power Output in Cardiogenic Shock Patients

Heart Failure
NCT04590690
Recruiting

Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric Surgery

Bariatric Surgery Candidate
NCT06008860 Phase 4
Recruiting

A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection

COVID-19
NCT06837220
Recruiting

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

Nicotine Use Disorder
NCT06284421
Recruiting

Durometer for Measuring Uterine Tone

Uterine Tone Disorders
NCT03729180
Recruiting

The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery

Surgery
NCT06950788
Recruiting

Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant

Cirrhosis, Liver
NCT05783245
Recruiting

Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release

Carpal Tunnel Syndrome
NCT07065630 Phase 2
Recruiting

Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer

Head and Neck Cancer
NCT04857528
Recruiting

Detecting HPV DNA in Anal and Cervical Cancers

Cervical Cancer
NCT02747303 Phase 2
Recruiting

Frameless Stereotactic Radiosurgery for Intact Brain Metastases

Brain Metastases
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology